Tongwei Co., Ltd. plans to acquire 100% equity of Lihao Qingneng; Sansheng Guojian's net profit attributable to the parent in 2025 is expected to increase by over 300% year-on-year | Selected Announcements

Reporter ****** | Chen Qing ******

****** Editor ******** | **** Chen Keming ** Wei Wenyí Dù Héngfēng Proofreading | Chéng Péng

Mergers and Acquisitions

Shenlian Biotech: Plans to Acquire Controlling Stake in Associate Company for 237 Million Yuan

On February 24, Shenlian Biotech announced that the company intends to use 237 million yuan of its own and self-raised funds (including bank acquisition loans) through its wholly-owned subsidiary Shanghai Bontiancheng Biopharmaceutical Co., Ltd., to acquire a controlling stake in the associate company Yangzhou Shizhiyuan Biotechnology Co., Ltd. via equity transfer and capital increase.

Dongyangguang: Planning to Acquire Control of Dongshu No.1

On February 24, Dongyangguang announced that the company is planning to issue shares to acquire control of Yichang Dongshu No.1 Investment Co., Ltd., and raise supporting funds. The transaction is expected to constitute a major asset restructuring and be a related-party transaction, but will not result in a change of actual controller.

Tongwei Co.: Planning to Purchase 100% Equity of Lihao Qingneng

On February 24, Tongwei Co. announced that it is planning to acquire 100% equity of Lihao Qingneng through issuing shares and cash payments, and to raise supporting funds. The company has signed an “Letter of Intent” with transaction parties including Duan Yong. The transaction is not expected to constitute a major asset restructuring nor lead to a change in control.

Changxin Bochuang: Intends to Acquire 93.8108% Equity of Shanghai Honghui Guanglian

On February 24, Changxin Bochuang announced that it signed a letter of intent with Shanghai Honghui Guangtong Technology Co., Ltd., to acquire 93.8108% of its equity in Shanghai Honghui Guanglian Communications Technology Co., Ltd., with an initial proposed price of 375 million yuan. The acquisition aims to expand the company’s upstream product lines in the optical communication industry chain and improve profitability and sustainable operations.

Performance Disclosure

Wens Foodstuffs: Net Profit Attributable to Parent in 2025 Down 43.59% Year-over-Year

On February 24, Wens Foodstuffs released its performance brief, reporting total revenue of 103.884 billion yuan in 2025, down 1.67% YoY; net profit attributable to parent of 5.235 billion yuan, down 43.59%.

Sansheng Guojian: Net Profit Attributable to Parent in 2025 Up 317.09% YoY

On February 24, Sansheng Guojian announced its performance brief, with revenue of 4.199 billion yuan in 2025, up 251.81% YoY; net profit attributable to parent of 2.939 billion yuan, up 317.09%.

Supor: Slight Revenue Increase in 2025, Net Profit Down 6.58% YoY

On February 24, Supor announced that in 2025, total revenue reached 22.772 billion yuan, up 1.54%; net profit attributable to parent was 2.097 billion yuan, down 6.58%.

Share Reductions and Increases

Zhixin Precision: Directors Plan to Reduce Holdings by Up to 1.8562%

On February 24, Zhixin Precision announced that shareholder and director Zhang Guojun, holding 8.83%, plans to reduce his holdings by up to 990,000 shares (1.8562% of total shares) through centralized bidding or block trades.

Runda Medical: Shareholders and Executives Plan to Reduce Holdings by Up to 3%

On February 24, Runda Medical announced that as of the disclosure date, director and executive Liu Hui held 31.53 million shares (5.22%), and shareholder Zhu Wenyí held 28.84 million shares (4.78%), both being parent and child. Liu Hui plans to reduce no more than 7.46 million shares (1.24%), and Zhu Wenyí no more than 10.54 million shares (1.75%).

Fushi Holdings: Shareholder Song Chunjing Plans to Reduce Holdings by Up to 2%

On February 24, Fushi Holdings announced that shareholder Song Chunjing, holding 5.97%, plans to reduce no more than 19.2777 million shares (2.00%), including no more than 9.6388 million shares (1.00%) through centralized bidding, due to personal funding needs.

Disclaimer: The content and data in this article are for reference only and do not constitute investment advice. Please verify before use. Operate at your own risk.

Daily Economic News